Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Drops By 33.9%

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 4,100 shares, a decline of 33.9% from the November 30th total of 6,200 shares. Based on an average daily volume of 34,900 shares, the short-interest ratio is presently 0.1 days.

Bavarian Nordic A/S Stock Up 0.8 %

BVNRY traded up $0.26 on Friday, hitting $8.98. The company’s stock had a trading volume of 8,435 shares, compared to its average volume of 32,110. The firm has a market cap of $2.12 billion, a P/E ratio of 13.01 and a beta of 1.65. Bavarian Nordic A/S has a 12 month low of $6.86 and a 12 month high of $14.60. The company’s 50 day simple moving average is $9.43 and its 200-day simple moving average is $10.00.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.